Rheumatoid arthritis

Incidence and spectrum of primary respiratory disease throughout the course of rheumatoid arthritis: implications of structured repeated evaluation for detection and risk-factor analysis

Arthritis Res TherPublished Retrospective cohort study

Authors' conclusion

Proactive screening identified a high incidence of ILD and airway disease in early RA

Study context

Population
Early RA patients screened for lung involvement at RA onset and during follow-up
Participants
204 patients
Outcome
Incidence and spectrum of lung involvement
Follow-up
4 and 8 years
Methodological detailsstructured repeated respiratory screening, Cox regression
  • Structured repeated respiratory screening
  • Cox regression

Main finding

As reported in the abstract

Pulmonary involvement
Pulmonary involvement, n/N (%)
89 of 204 (43.6%)
Cumulative incidence at 4 years
17.5%
Cumulative incidence at 8 years
25.2%
Incidence rate (IR) per 1,000 person-years, without prior lung disease
42.0
IR per 1,000 person-years, including pre-existing cases
50.2
Asymptomatic lung involvement detected by screening
51/204

Observational data: associations, not effects.

Further findings

Risk factors: age at RA onset ≥ 60 years

HR (95% CI)
Age at RA onset ≥ 60 yearsOverall lung involvement; independent association2.22 (1.20–4.11)
Age at RA onset ≥ 60 yearsILD3.36 (1.23–9.20)
Age at RA onset ≥ 60 yearsBronchiectasis2.42 (1.07–5.43)

Risk factors: male sex and interstitial lung disease (ILD)

HR (95% CI)
Male sexILD5.11 (1.52–17.13)

Frequency of manifestations

ILD
22.5%
Bronchiectasis
22.1%
Follicular bronchiolitis
7.8%
Pulmonary nodules
5.4%
Pleural disease
3.4%
Obliterative bronchiolitis
1%

IR by manifestation

Bronchiectasis
20.4
ILD
16.2
Follicular bronchiolitis
6.9
Nodules
4.9
Pleural disease
2.0
Obliterative bronchiolitis
1.0

Cumulative incidence by manifestation · 4 and 8 years

Bronchiectasis, 4 years
8.8%
Bronchiectasis, 8 years
12.9%
ILD, 4 years
7.5%
ILD, 8 years
11.6%

Original publication

Incidence and spectrum of primary respiratory disease throughout the course of rheumatoid arthritis: implications of structured repeated evaluation for detection and risk-factor analysis. Arthritis Res Ther. Published 23 January 2026. doi:10.1186/s13075-026-03736-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.